Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (Q38324480)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alessandro Leuti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Mauro Maccarrone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

20 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmune Pharmacology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

268-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11481-015-9584-2

28 February 2020

exact match

0 references

cites work

CB2: a cannabinoid receptor with an identity crisis

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The origin and cell lineage of microglia: new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Astrocytes and brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Controlled clinical trial of cannabidiol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Epigenetic mechanisms and endocannabinoid signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoids and innate immunity: taking a toll on neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Chemical constituents of marijuana: the complex mixture of natural cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Synthetic cannabinoids: analysis and metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

A molecular link between the active component of marijuana and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Origin and differentiation of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Microglial and macrophage polarization—new prospects for brain repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The ground state of innate immune responsiveness is determined at the interface of genetic, epigenetic, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The search for selective ligands for the CB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Design, Synthesis and Pharmacology of Cannabimimetic Indoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

A systematic review of pharmacological pain management in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Immune players in the CNS: the astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Toll-like receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid-based drugs as anti-inflammatory therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Common non-epigenetic drugs as epigenetic modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Neuroscience. Low-cost travel in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Novel cannabinol probes for CB1 and CB2 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabidiol--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Early phytocannabinoid chemistry to endocannabinoids and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Microglia development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid CB(2) receptors in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Astrocyte reactivity and reactive astrogliosis: costs and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Differential changes in GPR55 during microglial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

From surface to nuclear receptors: the endocannabinoid family extends its assets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Potential control of multiple sclerosis by cannabis and the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Epigenetic control of skin differentiation genes by phytocannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Gone to Pot - A Review of the Association between Cannabis and Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Regulation of MHC class II gene expression by the class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Regulation of innate immune responses in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Huntington's disease: from molecular pathogenesis to clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Agonistic properties of cannabidiol at 5-HT1a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoids: novel medicines for the treatment of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Neuroprotective agents: cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Molecular and clinical prodrome of Parkinson disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

The immune pathogenesis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

TRPV1 signaling: mechanistic understanding and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-015-9584-2

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

21 January 2018

1 reference

12 December 2020

The blood-brain barrier in neuroimmunology: Tales of separation and assimilation

1 reference

12 December 2020

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

12 December 2020

Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.

1 reference

12 December 2020

The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells

1 reference

12 December 2020

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.

1 reference

12 December 2020

Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes

1 reference

12 December 2020

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

12 December 2020

Cannabinoids for the treatment of inflammation.

1 reference

12 December 2020

Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity

1 reference

12 December 2020

GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor

1 reference

12 December 2020

Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors.

1 reference

12 December 2020

Cannabinoid pharmacology: the first 66 years

1 reference

12 December 2020

10.1007/S11481-015-9584-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601726%20AND%20SRC:MED&resulttype=core&format=json